Showing 100,921 - 100,940 results of 104,446 for search '(( a step decrease ) OR ( 5 ((((mean decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.83s Refine Results
  1. 100921

    Data_Sheet_1_Changes in Metabolism and Proteostasis Drive Aging Phenotype in Aplysia californica Sensory Neurons.PDF by Nicholas S. Kron (9377615)

    Published 2020
    “…The marine mollusk Aplysia californica (Aplysia) is a premier model for the nervous system uniquely suited to investigation of neuronal aging due to uniquely identifiable neurons and molecular techniques available in this model. …”
  2. 100922

    Data_Sheet_3_Changes in Metabolism and Proteostasis Drive Aging Phenotype in Aplysia californica Sensory Neurons.XLSX by Nicholas S. Kron (9377615)

    Published 2020
    “…The marine mollusk Aplysia californica (Aplysia) is a premier model for the nervous system uniquely suited to investigation of neuronal aging due to uniquely identifiable neurons and molecular techniques available in this model. …”
  3. 100923

    <b>Gene x environment interactions as drivers of lifespan variation in nematodes</b> by Justin Havird (2812975)

    Published 2025
    “…Healthspan (measured as worm activity) generally decreased with age, but in different ways for different genetic strains. …”
  4. 100924

    DataSheet_1_Increased PD-1+Foxp3+ γδ T cells associate with poor overall survival for patients with acute myeloid leukemia.pdf by Jiamian Zheng (12067958)

    Published 2022
    “…</p>Results<p>We found that PD-1 gene was positively correlated with FOXP3 gene and highly co-expressed PD-1 and FOXP3 genes were associated with poor overall survival (OS) from TCGA database. Then, we detected a skewed distribution of γδ T cells with increased Vδ1 and decreased Vδ2 T cell subsets in AML. …”
  5. 100925
  6. 100926

    Table3_Association between OPG polymorphisms and osteoporosis risk: An updated meta-analysis.docx by Xu Han (141301)

    Published 2022
    “…At the same time, the OPG G1181C polymorphism reduces the risk of osteoporosis (C vs G: OR = 0.84, 95% CI = 0.74–0.95; CC vs GG: OR = 0.75, 95% CI = 0.60–0.93; GC + CC vs GG: OR = 0.80, 95% CI = 0.67–0.95; CC vs GG + GC: OR = 0.84, 95% CI = 0.70–1.00). Moreover, a significantly decreased risk of osteoporosis was also discovered in Asian (C vs G: OR = 0.80, 95% CI = 0.66–0.98; CC vs GG: OR = 0.67, 95% CI = 0.47–0.95; GC + CC vs GG: OR = 0.74, 95% CI = 0.58–0.95) and the female (C vs G: OR = 0.85, 95% CI = 0.75–0.97; CC vs GG: OR = 0.77, 95% CI = 0.61–0.96; GC + CC vs GG: OR = 0.79, 95% CI = 0.66–0.95). …”
  7. 100927
  8. 100928
  9. 100929

    Table1_Association between OPG polymorphisms and osteoporosis risk: An updated meta-analysis.docx by Xu Han (141301)

    Published 2022
    “…At the same time, the OPG G1181C polymorphism reduces the risk of osteoporosis (C vs G: OR = 0.84, 95% CI = 0.74–0.95; CC vs GG: OR = 0.75, 95% CI = 0.60–0.93; GC + CC vs GG: OR = 0.80, 95% CI = 0.67–0.95; CC vs GG + GC: OR = 0.84, 95% CI = 0.70–1.00). Moreover, a significantly decreased risk of osteoporosis was also discovered in Asian (C vs G: OR = 0.80, 95% CI = 0.66–0.98; CC vs GG: OR = 0.67, 95% CI = 0.47–0.95; GC + CC vs GG: OR = 0.74, 95% CI = 0.58–0.95) and the female (C vs G: OR = 0.85, 95% CI = 0.75–0.97; CC vs GG: OR = 0.77, 95% CI = 0.61–0.96; GC + CC vs GG: OR = 0.79, 95% CI = 0.66–0.95). …”
  10. 100930

    Table2_Association between OPG polymorphisms and osteoporosis risk: An updated meta-analysis.docx by Xu Han (141301)

    Published 2022
    “…At the same time, the OPG G1181C polymorphism reduces the risk of osteoporosis (C vs G: OR = 0.84, 95% CI = 0.74–0.95; CC vs GG: OR = 0.75, 95% CI = 0.60–0.93; GC + CC vs GG: OR = 0.80, 95% CI = 0.67–0.95; CC vs GG + GC: OR = 0.84, 95% CI = 0.70–1.00). Moreover, a significantly decreased risk of osteoporosis was also discovered in Asian (C vs G: OR = 0.80, 95% CI = 0.66–0.98; CC vs GG: OR = 0.67, 95% CI = 0.47–0.95; GC + CC vs GG: OR = 0.74, 95% CI = 0.58–0.95) and the female (C vs G: OR = 0.85, 95% CI = 0.75–0.97; CC vs GG: OR = 0.77, 95% CI = 0.61–0.96; GC + CC vs GG: OR = 0.79, 95% CI = 0.66–0.95). …”
  11. 100931

    Table4_Association between OPG polymorphisms and osteoporosis risk: An updated meta-analysis.docx by Xu Han (141301)

    Published 2022
    “…At the same time, the OPG G1181C polymorphism reduces the risk of osteoporosis (C vs G: OR = 0.84, 95% CI = 0.74–0.95; CC vs GG: OR = 0.75, 95% CI = 0.60–0.93; GC + CC vs GG: OR = 0.80, 95% CI = 0.67–0.95; CC vs GG + GC: OR = 0.84, 95% CI = 0.70–1.00). Moreover, a significantly decreased risk of osteoporosis was also discovered in Asian (C vs G: OR = 0.80, 95% CI = 0.66–0.98; CC vs GG: OR = 0.67, 95% CI = 0.47–0.95; GC + CC vs GG: OR = 0.74, 95% CI = 0.58–0.95) and the female (C vs G: OR = 0.85, 95% CI = 0.75–0.97; CC vs GG: OR = 0.77, 95% CI = 0.61–0.96; GC + CC vs GG: OR = 0.79, 95% CI = 0.66–0.95). …”
  12. 100932
  13. 100933
  14. 100934
  15. 100935
  16. 100936
  17. 100937
  18. 100938
  19. 100939
  20. 100940